Abbott Laboratories financial data

Symbol
ABT on NYSE
Industry
Pharmaceutical Preparations
Location
100 Abbott Park Road, Abbott Park, IL
State of incorporation
IL
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 164 % -2.17%
Quick Ratio 46.9 % -2.31%
Return On Equity 32.2 % +113%
Return On Assets 17.8 % +127%
Operating Margin 16.3 % +0.74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.73B shares -0.05%
Entity Public Float 177B USD -4.37%
Common Stock, Value, Issued 25.2B USD +1.14%
Weighted Average Number of Shares Outstanding, Basic 1.74B shares 0%
Weighted Average Number of Shares Outstanding, Diluted 1.75B shares -0.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 42B USD +4.59%
Research and Development Expense 2.84B USD +3.76%
Costs and Expenses 35.1B USD +4.44%
Operating Income (Loss) 6.83B USD +5.36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.01B USD +5.24%
Income Tax Expense (Benefit) -6.39B USD -779%
Net Income (Loss) Attributable to Parent 13.4B USD +134%
Earnings Per Share, Basic 7.67 USD/shares +134%
Earnings Per Share, Diluted 7.64 USD/shares +134%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.62B USD +10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 6.93B USD +5.48%
Inventory, Net 6.19B USD -5.72%
Assets, Current 23.7B USD +4.35%
Property, Plant and Equipment, Net 10.7B USD +4.96%
Operating Lease, Right-of-Use Asset 1.08B USD -4.19%
Intangible Assets, Net (Excluding Goodwill) 6.65B USD -24.6%
Goodwill 23.1B USD -2.41%
Assets 81.4B USD +11.2%
Employee-related Liabilities, Current 1.7B USD +6.51%
Liabilities, Current 14.2B USD +2.28%
Operating Lease, Liability, Noncurrent 896M USD -5.59%
Other Liabilities, Noncurrent 3.44B USD -0.66%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.91B USD -0.86%
Retained Earnings (Accumulated Deficit) 47.3B USD +25.8%
Stockholders' Equity Attributable to Parent 47.7B USD +23.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 47.9B USD +23.4%
Liabilities and Equity 81.4B USD +11.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.03B USD -10.3%
Net Cash Provided by (Used in) Financing Activities -1.18B USD +16.6%
Net Cash Provided by (Used in) Investing Activities -425M USD +8.01%
Common Stock, Shares Authorized 2.4B shares 0%
Common Stock, Shares, Issued 1.99B shares +0.18%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -612M USD +15.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.62B USD +10.4%
Deferred Tax Assets, Valuation Allowance 1.66B USD -80.9%
Deferred Tax Assets, Gross 12.1B USD +4.5%
Operating Lease, Liability 1.15B USD -3.69%
Depreciation 333M USD +5.71%
Payments to Acquire Property, Plant, and Equipment 398M USD +4.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 13.3B USD +125%
Lessee, Operating Lease, Liability, to be Paid 1.32B USD -3.23%
Property, Plant and Equipment, Gross 22.7B USD +3.68%
Operating Lease, Liability, Current 254M USD +3.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 252M USD +2.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 290M USD +4.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 168M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 183M USD -11.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 3.57B USD +7.37%
Lessee, Operating Lease, Liability, to be Paid, Year Four 134M USD -8.22%
Amortization of Intangible Assets 1.88B USD -4.48%
Deferred Tax Assets, Net of Valuation Allowance 10.4B USD +264%
Interest Expense 625M USD +7.76%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%